Physician profile
Carol Ann Mcintyre
NPI 1477132199
$251.16
in general payments reported to CMS, 2019-2025
9 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.43 · 2024: $87.99 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $55.68 | 2024 | Restrata Wound Matrix |
| Urgo Medical North America, LLC | $50.23 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Ethicon US, LLC | $34.82 | 2025 | Ethicon, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Merck Sharp & Dohme LLC | $24.38 | 2025 | Zerbaxa |
| Vertex Pharmaceuticals Incorporated | $23.10 | 2025 | |
| Integra Lifesciences Corporation | $18.30 | 2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Boston Scientific Corporation | $16.16 | 2025 | Spyglass Discover |
| Ossur Americas, INC. | $14.48 | 2025 | |
| Smith+Nephew, INC. | $14.01 | 2024 | Stravix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.